WebOct 19, 2024 · The primary endpoint was ORR assessed by independent radiological review committee (IRRC) per RECIST v1.1; confirmation of complete response and partial response was required after 28 days.
NCI protocol 10250: A phase II study of temozolomide and …
WebThe primary endpoint was objective response rate (ORR) at 8 weeks assessed by investigators (power of 90%, alpha risk at 5% two-sided). Other endpoints included progression-free survival (PFS), overall survival ... Nivo+Ipi only reached the primary endpoint in 2nd/3rd line NECs pts with acceptable toxicity. Clinical trial identification ... WebJan 27, 2024 · The trial met its primary endpoint of an improvement in ORR, as assessed by an independent review committee, in patients treated with Enhertu compared to investigator’s choice of chemotherapy (irinotecan or paclitaxel monotherapy). Enhertu also showed a statistically significant and clinically meaningful improvement in OS, a key … rockler promotions deals \u0026 discounts
Response rate of anticancer drugs approved by the Food and Drug ...
WebNov 24, 2024 · Asymptomatic, stable CNS metastases were allowed. Primary endpoint: objective response rate (ORR) per RECIST 1.1 by blinded independent central review … WebMay 28, 2024 · Results: A total of 36 drugs received primary approval for the treatment of solid tumors between 2015 and 2024. Of the 40 supporting trials, ORR was the primary endpoint for 21 (52.5%), progression-free survival for 13 (32.5%), and overall survival for 2 (5.0%). ORR was evaluated in 35 of the 40 trials (87.5%). WebNov 8, 2024 · The primary endpoint of the study was the OS rate at two years, and the secondary endpoints included PFS and total PFS, defined as the time to second progression. Of note, the study was not powered to compare the three treatment arms. Despite the small study population, after an mFU of 32.2 months, the mOS was not reached in any of the … rockler professional